Compositions and methods for treatment of cardiovascular disorders and diseases
CA 2547053 C · Owner: Youdim, Moussa B. H. · Inventors: Barac, Yaron; Binah, Ofer; Youdim, Moussa B. H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan and analogs thereof, and pharmaceutically acceptable salts thereof are useful , for prevention or treatment of cardiovascular disorders and diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 28, 2004 and granted May 27, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 28, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 28, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.